on SENSORION (EPA:ALSEN)
Sensorion Announces Participation in June 2024 Investor Conferences
Montpellier, May 28, 2024 – Sensorion (FR0012596468 – ALSEN), a biotech company specializing in hearing loss therapies, will attend various investor conferences in June 2024.
Sensorion will participate in the Jefferies Global Healthcare Conference on June 5-6, 2024, in New York, USA. The management team will be available for one-on-one meetings on June 6, 2024.
Additionally, Sensorion will attend the Goldman Sachs 45th Annual Global Healthcare Conference on June 10-13, 2024, in Miami, USA. The Company will hold investor meetings on June 12 and 13, 2024.
Lastly, Sensorion will be present at Stifel’s European Healthcare Summit Lyon on June 25-27, 2024, in Lyon, France. The management team will be available for one-on-one meetings on June 26, 2024.
R. E.Copyright © 2024 FinanzWire, all reproduction and representation rights reserved. Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all SENSORION news